CURRICULUM VITAE. EDUCATION 10/ /2013 Ph.D. in Molecular Medicine (School of Medicine, University of Torino, Italy)
|
|
- Lynn Flowers
- 7 years ago
- Views:
Transcription
1 PERSONAL INFORMATION CURRICULUM VITAE EDUCATION 10/ /2013 Ph.D. in Molecular Medicine (School of Medicine, University of Torino, Italy) 10/ /2006 B.Sc., M.Sc. in Biomedical Sciences, University of Torino, Italy RESEARCH AND PROFESSIONAL EXPERIENCES 01/11/2015 now 01/ /2015 Universitatsspital Basel, Basel, Switzerland Position: Post Doc, Laboratory of Cancer Immunotherapy Supervisor: Prof. Alfred Zippelius Washington University School of Medicine, St. Louis (MO), USA Position: Post Doc Research Associate Supervisor: Prof. Roberta Faccio Dickkopf-related protein 1 (Dkk1) regulates the expansion and function of myeloid derived suppressor cells in cancer. 06/ /2013 Washington University School of Medicine, St. Louis (MO), USA Position: PhD student (last year of PhD programme) Supervisor: Prof. Roberta Faccio 10/ /2013 University of Torino, School of Medicine, Molinette Hospital, Italy Position: PhD student Supervisor: Prof. Mirella Giovarelli, Dr. Riccardo Ferracini. Characterization of breast cancer stem-like cells ability to metastasize to bone: a human in mice model of bone metastasis (Ph.D. thesis title). 09/ /2009 CeRMS (Center for Research and Medical Studies), Molinette Hospital, Italy Position: Research Fellow Supervisor: Dr. Riccardo Ferracini Role of kidney, breast and lung cancer stem cells in promoting bone metastases 10/ /2006 Department of Molecular Biology, Molinette Hospital, University of Torino, Italy Position: M.Sc. student Supervisor: Prof. Enzo Ghigo. Prof. Alloatti Growth hormone-releasing hormone GHRH promotes surivival of cardiac myocytes in vitro and protect against ischaemia-reperfusion in rat heart (M.Sc. thesis title) Lucia D Amico, PhD 1
2 TEACHING AND SUPERVISION EXPERIENCE /2015 Supervisor of PhD students, Prof. Faccio R, Washington University School of Medicine, St. Louis (USA). TECHNICAL SKILLS More than 6 years of experience in animal tumor models (LTK1 and LTK2 certificates) Strong experience with mammalian cell culture, PBMC isolation/ handling, murine cell isolation, and establishment of primary cell cultures Strong experience in phenotypic and functional characterization of mouse and human immune cells by FACS, ELISA/ELISPOT. Strong experience with bead cell sorting (MACS or Auto-MACS) Good experience in Immunofluorescence and IHC analysis LANGUAGES Italian: native speaker English : excellent command / highly proficient in spoken and written English French: basic communication skills / working knowledge Lucia D Amico, PhD 2
3 SCIENTIFIC PUBLICATIONS 1. D Amico L, Capietto AH, Zamani Ali, Bumpass David, Weilbaecher K, Denardo D, Faccio R. Dickkopfrelated protein 1 (Dkk1) regulates the expansion and function of myeloid derived suppressor cells in cancer. J Exp Med. 2016, Apr 4. pii: jem Voena C, Menotti M, Mastini C, Di Giacomo F, Longo DL, Castella B, Merlo ME, Ambrogio C, Wang Q, Minero VG, Poggio T, Martinengo C, D'Amico L, Panizza E, Mologni L, Cavallo F, Altruda F, Butaney M, Capelletti M, Inghirami G, Jänne PA, Chiarle R. Efficacy of a Cancer Vaccine against ALK- Rearranged Lung Tumors. Cancer Immunol Res Dec;3(12): Bertolini G, D'Amico L, Moro M, Landoni E, Perego P, Miceli R, Gatti L, Andriani F, Wong D, Caserini R, Tortoreto M, Milione M, Ferracini R, Mariani L, Pastorino U, Roato I, Sozzi G, Roz L. Microenvironment modulated metastatic CD133+/CXCR4+/EpCAM- lung cancer initiating cells sustain tumor dissemination and correlate with poor prognosis. Cancer Res Sep 1;75(17): D'Amelio P, Sassi F, Buondonno I, Fornelli G, Spertino E, D'Amico L, Marchetti M, Lucchiari M, Roato I, Isaia GC. Treatment with intermittent PTH increases Wnt10b production by T cells in osteoporotic patients. Osteoporos Int Jun D'Amico L, Roato I. The Impact of Immune System in Regulating Bone Metastasis Formation by Osteotropic tumors. JImmunol Res. 2015;2015: Voena C, Di Giacomo F, Panizza E, D'Amico L, Boccalatte FE, Pellegrino E, Todaro M, Recupero D, Tabbò F, Ambrogio C, Martinengo C, Bonello L, Pulito R, Hamm J, Chiarle R, Cheng M, Ruggeri B, Medico E, Inghirami G. The EGFR family members sustain the neoplastic phenotype of ALK+ lung adenocarcinoma via EGR1. Oncogenesis Apr 8;2:e43 7. D'Amico L, Patanè S, Grange C, Bussolati B, Isella C, Fontani L, Godio L, Cilli M, D'Amelio P, Isaia G, Medico E, Ferracini R, Roato I. Primary breast cancer stem-like cells metastasise to bone, switch phenotype and acquire a bone tropism signature. Br J Cancer Jun 25;108(12): D'Amico L, Satolli MA, Mecca C, Castiglione A, Ceccarelli M, D'Amelio P, Garino M, De Giuli M, Sandrucci S, Ferracini R, Roato I. Bone metastases in gastric cancer follow a RANKL-independent mechanism. Oncol Rep Apr;29(4): D Amico L., Ruffini E., Ferracini R., Roato I. Low dose of IL-12 stimulates T cell response in cultures of PBMCs derived from Non Small Cell Lung Cancer patients. Journal of Cancer Therapy, 2012, 3, doi: /jct D Amico L., Roato I. Cross-talk between T cells and osteoclasts in bone resorption. BoneKEy Reports 2012 June 6;82(2012) doi: /bonekey D'Amelio P, Tamone C, Sassi F, D'Amico L, Roato I, Patanè S, Ravazzoli M, Veneziano L, Ferracini R, Pescarmona GP, Isaia GC. Teriparatide increases the maturation of circulating osteoblast precursors. Osteoporos Int Apr;23(4): D'Amelio P, Cristofaro MA, D'Amico L, Veneziano L, Roato I, Sassi F, Bisignano G, Saracco M, Pellerito R, Patane S, Ferracini R, Pescarmona GP, Isaia GC. Iloprost modulates the immune response in systemic sclerosis. BMC Immunol Dec 15;11(1): Roato I., Porta F., Mussa A., D'Amico L., Fiore L., Garelli D., Spada M., Ferracini R. Bone impairment in phenylketonuria is characterized by circulating osteoclast precursors and activated T cell increase. Plos One Lucia D Amico, PhD 3
4 2010 Nov 30;5(11):e D Amelio P, Roato I, D Amico L. Veneziano L, Suman E, Sassi F, Bisignano G, Ferracini R, Gargiulo G, Castoldi F, Pescarmona GP, Isaia GC. Bone and bone-marrow pro-osteoclastogenic cytokines are up-regulated in osteoporosis fragility fractures. Osteoporos Int., 2010 Nov 30, I. Roato, D. Caldo, L. D Amico, P. D Amelio, L. Godio, S. Patanè, F. Astore, G Grappiolo, M.Boggio, R. Scagnelli, L. Molfetta, R. Ferracini. Osteoclastogenesis in peripheral blood mononuclear cell cultures of periprosthetic osteolysis patients and the phenotype of T cells localized in periprosthetic tissues. Biomaterials 2010 Oct;31(29): Roato I, Caldo D, Godio L, D'Amico L, Giannoni P, Morello E, Quarto R, Molfetta L, Buracco P, Mussa A, Ferracini R. Bone invading NSCLC cells produce IL-7: mice model and human histologic data. BMC Cancer Jan 12;10(1): Boccalatte FE, Voena C, Riganti C, Bosia A, D'Amico L, Riera L, Cheng M, Ruggeri B, Jensen ON, Goss VL, Lee K, Nardone J, Rush J, Polakiewicz RD, Comb MJ, Chiarle R, Inghirami G. The enzymatic activity of 5- aminoimidazole-4-carboxamide ribonucleotide formyltransferase/imp cyclohydrolase (ATIC) is enhanced by NPM-ALK: new insights in ALK-mediated pathogenesis and the treatment of ALC. Blood. 2009,Mar 19;113(12): PROCEEDINGS: Satolli M., Roato I., D amico L, Mecca C., Ferracini R., Bussolati G., De Giuli M., Garetto M., Ciuffreda L., Mussa A. Mechanisms of bone metastases in gastric carcinoma (GC): preliminary results of a biological and clinical study. Annals of Oncology 2010, 21:1-132 BOOK CHAPTER: Lucia D Amico, Ilaria Roato. Osteoclasts: Morphology, Functions and Clinical Implications. Edited by: Alexander J. Brown and Johanna S. Walker Nova Science Publishers. AWARDS 10/ / / American Society for Bone and Mineral Research (ASBMR),Young Investigator Award 2015, Seattle,USA Musculoskeletal Research Center, Washington University St. Louis, MO, USA ASBMR Travel Award, Houston, USA Best Italian Project, National Congress of Italian Society of Osteoncology (ISO) Selected posters presented by the author: L. D Amico, Roberta Faccio. Musculoskeletal Symphosium, Washington University School of Medicine, St. Louis, Travel Award. L. D Amico, Capietto Aude Helene, Zamani Ali, Roberta Faccio. American Society of Bone and Mineral Research, Annual Meeting 2014, Houston, Texas, USA. Plennary poster presentation. ASBMR Young Investigator Travel Award. Lucia D Amico, PhD 4
5 L. D Amico, Patanè S., Grange C., Bussolati B., Cilli M. D Amelio P., Isaia GC., Ferracini R., Roato I. Breast cancer stem cells metastatize to bone in a human in mice model. American Society of Bone and Mineral Research, Annual Meeting, 2011, San Diego, California, USA. L. D Amico, I. Roato, S. Patanè, G. Bertolini, B. Bussolati, R. Ferracini. Cancer stem cells promote bone metastasis in osteotropic tumors. 3 rd Joint meeting of ECTS and IBMS, May , Athene, Greece. I. Roato, L. D'Amico, F. Porta, A. Mussa,.R. Ferracini. Role of T cells in the activation of osteoclastogenesis in phenylketonuria patients. American Society of Bone and Mineral Research, Annual Meeting, October , Toronto, Canada. Oral presentation (invited speaker) 11/10/2015 American Society for Bone and Mineral Research (ASBMR), Seattle, USA Lucia D Amico, PhD 5
ELENCO DELLE PUBBLICAZIONI E DEI TITOLI DEL CANDIDATO
ELENCO DELLE PUBBLICAZIONI E DEI TITOLI DEL CANDIDATO RICCARDO FERRACINI Nato il 28/04/1958 Pubblicazioni scientifiche 1. 2. 3. 4. 5. 6. 2013 - Articolo in rivista D'Amico L, Satolli MA, Mecca C, Castiglione
More informationPathophysiology of bone metastasis : how does it apply to pain treatment in palliative care? JP Vuillez, Grenoble, France
Pathophysiology of bone metastasis : how does it apply to pain treatment in palliative care? JP Vuillez, Grenoble, France Bone metastases 70 % of prostate and breast cancers 30 % of lung, bladder and thyroid
More informationAmel Abd Allah Hashim Ahmed
Amel Abd Allah Hashim Ahmed Lecturer of Biochemistry & Molecular Biology PERSONAL PROFILE Nationality: Egyptian Work: Faculty of Pharmacy, Helwan University, Ain-Helwan, Helwan, Egypt. Work phone: 25590000-
More informationBIOMEDICAL SCIENCES GRADUATE PROGRAM FALL 2012
THE OHIO STATE UNIVERSITY BIOMEDICAL SCIENCES GRADUATE PROGRAM FALL 2012 Reeva Aggarwal PhD Candidate MECHANISMS OF HUMAN CD34+ STEM CELL-MEDIATED REGULATION OF OSTEOPOROSIS IN A PRECLINICAL MODEL November
More informationCurriculum Vitae SILVIA PREITE
Curriculum Vitae SILVIA PREITE PERSONAL DATA Current position:, Via Vincenzo Vela 6, 6500, Bellinzona (Switzerland) Cell phone: +41 767861119 or +39 3490541497 Email address: silvia.preite@irb.usi.ch,
More informationGIORGIO VITTORIO SCAGLIOTTI, M.D. CURRICULUM VITAE
GIORGIO VITTORIO SCAGLIOTTI, M.D. CURRICULUM VITAE Personal Information Date of birth July 2, 1953 Place of birth Torino, Italy Office address Department of Oncology S. Luigi Gonzaga Hospital, Oncology
More informationAnalysis One Code Desc. Transaction Amount. Fiscal Period
Analysis One Code Desc Transaction Amount Fiscal Period 57.63 Oct-12 12.13 Oct-12-38.90 Oct-12-773.00 Oct-12-800.00 Oct-12-187.00 Oct-12-82.00 Oct-12-82.00 Oct-12-110.00 Oct-12-1115.25 Oct-12-71.00 Oct-12-41.00
More informationThoracic Oncology Unit
F ORMATO EUROPEO PER IL CURRICULUM VITAE PERSONAL INFORMATION Name NOVELLO Silvia Address AOU S Luigi Gonzaga, Regione Gonzole 10, 10043 Orbassano, Torino Telephone +39-011-9026978 Fax +39-011-9038616
More informationModelli murini di linfomagenesi. Roberto Chiarle, M.D. Firenze, 24/11/2011
Modelli murini di linfomagenesi Roberto Chiarle, M.D. Firenze, 24/11/2011 Chromosomal translocations in tumors Translocation are common in many types of tumors and are often considered primary oncogenic
More informationDevelopment of Bone Metastases in Men With Prostate Cancer
Development of Bone Metastases in Men With Prostate Cancer Explore the Causes Understand the Consequences Natural History of Prostate Cancer Progression Many prostate tumors may become castrate-resistant
More informationOPG-Fc inhibits ovariectomy-induced growth of disseminated breast cancer cells in bone.
Title of the poster Authors Sheffield Cancer Research Centre University of Sheffield OPG-Fc inhibits ovariectomy-induced growth of disseminated breast cancer cells in bone. Dr Penelope Ottewell Background
More information10 th EADO Congress Vilnius, 7-10 May 2014. Ipilimumab update. Michele Maio
10 th EADO Congress Vilnius, 7-10 May 2014 Ipilimumab update Michele Maio Medical Oncology and Immunotherapy, Department of Oncology University Hospital of Siena, Istituto Toscano Tumori SIENA, ITALY Evolving
More informationPh.D. in Molecular Medicine
Ph.D. in Molecular Medicine and Translational Research College of Medicine 1. Introduction: The College of Medicine, while consolidating on its undergraduate innovative educational programs, decided to
More informationLCFA/IASLC LORI MONROE SCHOLARSHIP IN TRANSLATIONAL LUNG CANCER RESEARCH
LCFA/IASLC LORI MONROE SCHOLARSHIP IN TRANSLATIONAL LUNG CANCER RESEARCH FUNDING OPPORTUNITY DESCRIPTION 2016 REQUEST FOR APPLICATION (RFA) Lung Cancer Foundation of America (LCFA) and the International
More informationALCHEMIST (Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trials)
ALCHEMIST (Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trials) 3 Integrated Trials Testing Targeted Therapy in Early Stage Lung Cancer Part of NCI s Precision Medicine Effort in
More informationAT&T Global Network Client for Windows Product Support Matrix January 29, 2015
AT&T Global Network Client for Windows Product Support Matrix January 29, 2015 Product Support Matrix Following is the Product Support Matrix for the AT&T Global Network Client. See the AT&T Global Network
More informationCURRICULUM VITAE. Name: Florencia Licastro Job Title: Director, Training and Development. Summary of experience
CURRICULUM VITAE Name: Florencia Licastro Job Title: Director, Training and Development Summary of experience Over 11 years working in Clinical Research in a large CRO, starting as Clinical Research Associate,
More informationCONTRACTING ORGANIZATION: University of Alabama at Birmingham Birmingham, AL 35294
AD Award Number: W81XWH-08-1-0030 TITLE: Regulation of Prostate Cancer Bone Metastasis by DKK1 PRINCIPAL INVESTIGATOR: Gregory A. Clines, M.D., Ph.D. CONTRACTING ORGANIZATION: University of Alabama at
More informationCancerStemCell Markers in Lung Cancers: Proofsof. Reservations. Lourdes Cortes-Dericks, PhD University of Hamburg Hamburg, Germany
CancerStemCell Markers in Lung Cancers: Proofsof ConceptsandSome Reservations Lourdes Cortes-Dericks, PhD University of Hamburg Hamburg, Germany Lung cancer: highest death rate and poorest patient survival
More informationDecision to Continue the Development of Tecemotide (L-BLP25) in Non-Small Cell Lung Cancer to be Announced
September 27, 2013 ONO PHARMACEUTICAL CO., LTD. Corporate Communications Phone: +81-6-6263-5670 Decision to Continue the Development of Tecemotide (L-BLP25) in Non-Small Cell Lung Cancer to be Announced
More informationMULTIPLE MYELOMA. Dr Malkit S Riyat. MBChB, FRCPath(UK) Consultant Haematologist
MULTIPLE MYELOMA Dr Malkit S Riyat MBChB, FRCPath(UK) Consultant Haematologist Multiple myeloma is an incurable malignancy that arises from postgerminal centre, somatically hypermutated B cells.
More informationFulfilling the Promise
Fulfilling the Promise Advancing the Fight Against Cancer: America s Medical Schools and Teaching Hospitals For more than a century, the nation s medical schools and teaching hospitals have worked to understand,
More informationQuality and Clinical Director
Curriculum Vitae PERSONAL INFORMATION Minna Leppänen WORK EXPERIENCE April 2014 Present Quality and Clinical Director Scaffdex Ltd, (Finland) Responsibility in quality, regulatory and clinical issues concerning
More informationCurriculum Vitae. Personal information Name: Anna Surname: Puggina Date of Birth: 24/01/1987 Place of Birth: Dolo (VE), Italy Citizenship: Italian
Curriculum Vitae Personal information Name: Anna Surname: Puggina Date of Birth: 24/01/1987 Place of Birth: Dolo (VE), Italy Citizenship: Italian Contact information Address: Via San Pio X 7/a, 35122,
More informationCOMPARISON OF FIXED & VARIABLE RATES (25 YEARS) CHARTERED BANK ADMINISTERED INTEREST RATES - PRIME BUSINESS*
COMPARISON OF FIXED & VARIABLE RATES (25 YEARS) 2 Fixed Rates Variable Rates FIXED RATES OF THE PAST 25 YEARS AVERAGE RESIDENTIAL MORTGAGE LENDING RATE - 5 YEAR* (Per cent) Year Jan Feb Mar Apr May Jun
More informationCOMPARISON OF FIXED & VARIABLE RATES (25 YEARS) CHARTERED BANK ADMINISTERED INTEREST RATES - PRIME BUSINESS*
COMPARISON OF FIXED & VARIABLE RATES (25 YEARS) 2 Fixed Rates Variable Rates FIXED RATES OF THE PAST 25 YEARS AVERAGE RESIDENTIAL MORTGAGE LENDING RATE - 5 YEAR* (Per cent) Year Jan Feb Mar Apr May Jun
More informationIdentification of CD4+ T cell epitopes specific for the breast cancer associated antigen NY-BR-1
9/8/2015 Identification of CD4+ T cell epitopes specific for the breast cancer associated antigen NY-BR-1 Stefan Eichmüller, PhD GMP & T Cell Therapy Unit, German Cancer Research Center, Heidelberg, Germany
More informationOn the origin of giant multinuclear Reed-Sternberg cells and the role of CD4 T cells in Hodgkin lymphoma
On the origin of giant multinuclear Reed-Sternberg cells and the role of CD4 T cells in Hodgkin lymphoma Uber die Entstehung von multinuklearen Reed-Sternberg Riesenzellen und die Rolle von CD4 T-Zellen
More informationCurriculum Vitae Harvard Medical School/ Harvard School of Dental Medicine
Curriculum Vitae Harvard Medical School/ Harvard School of Dental Medicine Date Prepared: November 16, 2009 Name: Zafira Castaño Corsino, Ph.D. Work Phone: (34) 659306730 Work Email: Place of Birth: zcastan@hotmail.com
More informationThe EGFR mutation and precision therapy for lung cancer
for lung cancer Outcomes in advanced lung cancer have seen meaningful improvement in the past decade thanks to new precision drug therapies. Because tumors usually develop resistance to the drugs, scientists
More informationCURRICULUM VITAE. - Instructor, Department of Nutrition and Exercise Sciences, Oregon State University, Corvallis Oregon (2010-2011
CURRICULUM VITAE Personal Information Kathleen S. Howe, Ph.D. Instructor School of Biological and Population Health Sciences, College of Public Health and Human Sciences Oregon State University kathy.howe@oregonstate.edu
More informationOncology Central MEDIA PACK 2016 SPONSORSHIP ADVERTISING NETWORKING
Oncology Central MEDIA PACK 2016 SPONSORSHIP ADVERTISING NETWORKING Client opportunities CONTENTS About us...02 Readership...04 Driving qualified leads...05 Our Journals...08 Editorial Calendar...10 Rate
More informationUC Davis Institute for Regenerative Cures A facility supported by the California Institute for Regenerative Medicine
UC Davis Institute for Regenerative Cures A facility supported by the California Institute for Regenerative Medicine Naming Opportunities Opportunity No. Description/Features Gift Amount Institute for
More informationAvastin in breast cancer: Summary of clinical data
Avastin in breast cancer: Summary of clinical data Worldwide, over one million people are diagnosed with breast cancer every year 1. It is the most frequently diagnosed cancer in women 1,2, and the leading
More informationJUMISC JUMISC. For further information visit our website:
STEM CELL THERAPY COMPANY PROFILE & SCIENTIFIC ACTIVITIES For further information visit our website: WWW.CCMIJESUSUSON.COM 20 14 JUMISC JUMISC Carretera N-521, km. 41,8 10071 CÁCERES (SPAIN) Tel. (+34)
More informationCurriculum Vitae. Education: Research Associate (Sept. 2009- Current)
Curriculum Vitae Pramod Kumar Giri, Ph.D Research Associate, Department of Microbiology & Immunology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611 USA. Phone: Lab : 001-312-503-1093
More informationGiulia Cereda. Mathematical Institute, Leiden University, Master thesis research project
Giulia Cereda Personal Information Place and Date of Birth: Milano (Italy), April, 7 th 1988 Citizenship: Italian Current address: Av. de la Chabliere 21, 1004, Lausanne, Swizerland email: giulia.cereda@unil.ch
More informationWadsworth Center. New York State Department of Health. The New Faces BMS
New York State Department of Health The New Faces of BMS The New Faces of BMS Jason Wong Adriana DePesters Jason is enrolled in the PhD course for the Fall session in the Department of Biomedical Science.
More informationA disease and antibody biology approach to antibody drug discovery
A disease and antibody biology approach to antibody drug discovery Björn Frendéus, PhD VP, Preclinical research Presenter: Björn Frendéus Date: 2011-11-08 1 Antibodies have revolutionized Cancer Treatment!
More informationRecruiting now. Could you help by joining this study?
Non-Small Cell Lung Cancer Recruiting now AstraZeneca is looking for men and women with locally advanced or metastatic non-small cell lung cancer (NSCLC) to join ATLANTIC, a clinical study to help investigate
More information30-31. Advancesincancer immunologyand immunotherapy. announcement. October2015. Royal Olympic Hotel Athens
Advancesincancer immunologyand immunotherapy 30-31 October2015 Royal Olympic Hotel Athens announcement Organizer Hellenic Oncology Research Group (HORG) Symposium chairs N. Kentepozidis, A. Kotsakis, M.
More informationSommaire projets sélectionnés mesure 29: Soutien à la recherche translationnelle
Sommaire projets sélectionnés mesure 29: Soutien à la recherche translationnelle TITLE PROJET NOM HOPITAL Assessment of tumor angiogenesis using PET/CT with 18 F-Galacto- RGD. (PNC_29_001) Division of
More informationFuture Oncology: Technology, Products, Market and Service Opportunities
Brochure More information from http://www.researchandmarkets.com/reports/296370/ Future Oncology: Technology, Products, Market and Service Opportunities Description: Future Oncology is an analytical newsletter
More informationCancer Immunotherapy: Can Your Immune System Cure Cancer? Steve Emerson, MD, PhD Herbert Irving Comprehensive Cancer Center
Cancer Immunotherapy: Can Your Immune System Cure Cancer? Steve Emerson, MD, PhD Herbert Irving Comprehensive Cancer Center Bodnar s Law Simple Things are Important Very Simple Things are Very Important
More informationWhat is Cancer? Cancer is a genetic disease: Cancer typically involves a change in gene expression/function:
Cancer is a genetic disease: Inherited cancer Sporadic cancer What is Cancer? Cancer typically involves a change in gene expression/function: Qualitative change Quantitative change Any cancer causing genetic
More informationDIPARTIMENTO di SCIENZE BIOMEDICHE e BIOTECNOLOGICHE
July 15, 2015 Science editor of World Journal of Gastroenterology Jing Yu Email: j.yu@wjgnet.com Dear Prof. Jing Yu, please find enclosed a revised version of our paper Non-coding landscapes of Colorectal
More informationAriela Benigni. Biol.Sci.D., Ph.D. Curriculum Vitae
Ariela Benigni Biol.Sci.D., Ph.D. Curriculum Vitae Personal Data Name: Date and place of birth: Citizenship: E-mail: Ariela Benigni December 16, 1955 - Bergamo, Italy Italian ariela.benigni@marionegri.it
More informationImmuno-Oncology Model Application in the Preclinical Treatment Setting
Immuno-Oncology Model Application in the Preclinical Treatment Setting Maryland Franklin, Ph.D. Senior Director, Scientific Development mfranklin@molecularimaging.com July 22, 2015 Tumor Models Conference
More informationTECHNICAL INSIGHTS TECHNOLOGY ALERT
TECHNICAL INSIGHTS TECHNOLOGY ALERT UNLOCKING BREAST CANCER TUMORS' DRUG RESISTANCE A troubling phenomenon in breast cancer treatment is that some patients tumors become resistant to treatments over time.
More informationEnhancing Anti-Tumor Activity of Checkpoint Inhibition
Enhancing Anti-Tumor Activity of Checkpoint Inhibition Jeffrey Schlom, Ph.D. Laboratory of Tumor Immunology and Biology (LTIB) Center for Cancer Research National Cancer Institute, NIH Laboratory of Tumor
More informationtargeted therapy a guide for the patient
targeted therapy FOR LUNG CANCER a guide for the patient TABLE OF CONTENTS lung cancer basics... 2-3 Gene changes... 4-5 Testing... 7-8 Targeted therapy... 9-11 Drugs Targeting EGFR... 12 Drugs Targeting
More informationNuevas tecnologías basadas en biomarcadores para oncología
Nuevas tecnologías basadas en biomarcadores para oncología Simposio ASEBIO 14 de marzo 2013, PCB Jose Jimeno, MD, PhD Co-Founder / Vice Chairman Pangaea Biotech SL Barcelona, Spain PANGAEA BIOTECH BUSINESS
More informationH. Richard Alexander, Jr., M.D. Department of Surgery and The Greenebaum Cancer Center University of Maryland School of Medicine Baltimore, Md
Major Advances in Cancer Prevention, Diagnosis and Treatment~ Why Mesothelioma Leads the Way H. Richard Alexander, Jr., M.D. Department of Surgery and The Greenebaum Cancer Center University of Maryland
More informationBiology and BNCT: in vivo studies
Pavia University (Italy) Biology and BNCT: in vivo studies Nano Rosanna Departement of Animal Biology Legnaro, November 17-19, 2009 Efficacy of BNCT in liver metastases t PROGETTO TAOrMINA Trattamento
More informationFASEB Directory of Members Online
Head, Department of Anatomy and Radiology The College of Veterinary Medicine at the University of Georgia invites nominations and applications for the position of Head of the Department of Anatomy and
More informationANATOMY & PHYSIOLOGY MODULE 2015/16
ANATOMY & PHYSIOLOGY MODULE 2015/16 STUDENT INFORMATION MODULE CO-ORDINATOR: Email: edged@tcd.ie DEPARTMENT OF PHYSIOLOGY, BIOMEDICAL SCIENCES INSTITUTE, TRINITY COLLEGE, PEARSE STREET, DUBLIN 2. Module
More informationMedical & Health Sciences
School of Postgraduate Studies Medical & Health Sciences (MSc /PhD by Research) 2016 What Is IMU s Medical & Health Sciences (by Research) Programme About? Overview Postgraduate research forms a major
More informationScientific Programme
Scientific Programme Scientific Committee Hilary Calvert UCL Cancer Institute, London, UK Luca Gianni Ospedale San Raffaele IRCCS, Milan, Italy Ana Maria Gonzalez-Angulo Cristiana Sessa Istituto Oncologico
More informationCurriculum Vitae Michael M. Zavlanos
Curriculum Vitae Michael M. Zavlanos Home Address Work Address 2114 Pine Street 3330 Walnut Street Apartment 1 Front GRASP Laboratory, Levine Hall 465 Philadelphia, PA 19103 Dept. of Electrical and Systems
More informationPROSPETTIVE FUTURE NEL TRATTAMENTO. Cinzia Ortega Dipartimento di Oncologia Medica Fondazione del Piemonte per l Oncologia I.R.C.C.S.
PROSPETTIVE FUTURE NEL TRATTAMENTO MEDICO DEL mrcc Cinzia Ortega Dipartimento di Oncologia Medica Fondazione del Piemonte per l Oncologia I.R.C.C.S. Candiolo Future strategies in mrcc Improve therapeutic
More informationCase 2:08-cv-02463-ABC-E Document 1-4 Filed 04/15/2008 Page 1 of 138. Exhibit 8
Case 2:08-cv-02463-ABC-E Document 1-4 Filed 04/15/2008 Page 1 of 138 Exhibit 8 Case 2:08-cv-02463-ABC-E Document 1-4 Filed 04/15/2008 Page 2 of 138 Domain Name: CELLULARVERISON.COM Updated Date: 12-dec-2007
More informationGenomic Medicine The Future of Cancer Care. Shayma Master Kazmi, M.D. Medical Oncology/Hematology Cancer Treatment Centers of America
Genomic Medicine The Future of Cancer Care Shayma Master Kazmi, M.D. Medical Oncology/Hematology Cancer Treatment Centers of America Personalized Medicine Personalized health care is a broad term for interventions
More informationVersion 1 2015. Module guide. Preliminary document. International Master Program Cardiovascular Science University of Göttingen
Version 1 2015 Module guide International Master Program Cardiovascular Science University of Göttingen Part 1 Theoretical modules Synopsis The Master program Cardiovascular Science contains four theoretical
More informationTargeted Therapies in Lung Cancer
Targeted Therapies in Lung Cancer I Edited by: Simona Carnio Thoracic Oncology Division - St Luigi Hospital Orbassano (TO) - Italy Silvia Novello Department of Oncology - University of Torino - Italy Why
More informationPART 3.3: MicroRNA and Cancer
BIBM 2010 Tutorial: Epigenomics and Cancer PART 3.3: MicroRNA and Cancer Dec 18, 2010 Sun Kim at Indiana University Outline of Part 3.3 Background on microrna Role of microrna in cancer MicroRNA pathway
More informationComparing Immunotherapy with High Dose IL-2 and Ipilimumab
Comparing Immunotherapy with High Dose IL-2 and Ipilimumab Michael K Wong MD PhD FRCPC mike.wong@med.usc.edu Disclosures Speaker s Bureau, Advisory Boards, Consultant: Prometheus Bristol Myers Squibb Novartis
More informationImmuno-Oncology Therapies to Treat Lung Cancer
Immuno-Oncology Therapies to Treat Lung Cancer What you need to know ONCHQ14NP07519 Introduction: Immuno-oncology represents an innovative approach to cancer research that seeks to harness the body s own
More informationThe TV Series. www.healthybodyhealthymind.com INFORMATION TELEVISION NETWORK
The TV Series www.healthybodyhealthymind.com Produced By: INFORMATION TELEVISION NETWORK ONE PARK PLACE 621 NW 53RD ST BOCA RATON, FL 33428 1-800-INFO-ITV www.itvisus.com 2005 Information Television Network.
More informationSUMMARY. Randolph Fillmore, Florida Science Communications
SUMMARY Randolph Fillmore, Florida Science Communications The H. Lee Moffitt Cancer Center held its first Advanced Prostate Cancer Collaboration roundtable discussion November 24, 2008. The roundtable
More information2 Year (2013 15) CLL/SLL Research Initiative CLL/SLL Collaborative Grant
2 Year (2013 15) CLL/SLL Research Initiative CLL/SLL Collaborative Grant Guidelines & General Instructions for Application KEY DATES: Application Release Date: December 12, 2012 Application Deadline: February
More informationRegional Young Investigator SIC meeting. 5-6 March 2015
Regional Young Investigator SIC meeting 5-6 March 2015 Aula Magna A - Università Magna Graecia di Catanzaro - Campus Universitario S. Venuta Viale Europa, loc. Germaneto - Catanzaro Invited speakers: Rita
More informationMOLOGEN AG. Q1 Results 2015 Conference Call Dr. Matthias Schroff Chief Executive Officer. Berlin, 12 May 2015
Q1 Results 2015 Conference Call Dr. Matthias Schroff Chief Executive Officer Berlin, 12 May 2015 V1-6 Disclaimer Certain statements in this presentation contain formulations or terms referring to the future
More informationReport series: General cancer information
Fighting cancer with information Report series: General cancer information Eastern Cancer Registration and Information Centre ECRIC report series: General cancer information Cancer is a general term for
More informationOverall teaching planning and Istitutional tasks Antonio Cuneo (Hematology), Giovanni Lanza (Pathology)
Title of the programme "Normal and abnormal growth of tissues and organs", Discipline - Oncology Period June 2013 Teaching language English Maximum number of students 10 +10 Programme co-ordinators Contactperson
More informationSpecialized Master of Science in Experimental Biomedical Research
Curriculum for the award of the Degree of Specialized Master of Science in Experimental Biomedical Research options: Neuroscience Infection, Inflammation and Cancer Cardiovascular and Metabolic Health
More informationFrom Immunotherapy of Cancer to the Discovery of Kidney Cancer Genes
ISSN 2154-4006 The Genetic Basis of Human Disease zbar Colloquium series on Series Editor: Michael Dean, Ph.D., Head, Human Genetics Section, Senior Investigator, Laboratory of Experimental Immunology
More informationOral Health Care Practitioners Perceptions of Bisphosphonate Related Osteochemonecrosis of the Jaws
Oral Health Care Practitioners Perceptions of Bisphosphonate Related Osteochemonecrosis of the Jaws Student: Kelly Cottrell Preceptor: T Dolan DDS, MPH Mentor: J Nieto MPH, MD, PhD Outline: Background
More informationAvastin in breast cancer: Summary of clinical data
Avastin in breast cancer: Summary of clinical data Worldwide, over one million people are diagnosed with breast cancer every year 1. It is the most frequently diagnosed cancer in women 1,2, and the leading
More informationLIQUID BIOPSY: TRACKING CANCER
SYMPOSIUM LIQUID BIOPSY: TRACKING CANCER 29-30 April 2016 first announcement Pierre-Auguste Renoir Chemin montant dans les hautes herbes Organizing Secretariat CONGRESS LINE Via Cremona, 19-00161 Rome
More informationMetastasis. brain metastasis from bronchial carcinoma
metastasis Metastasis brain metastasis from bronchial carcinoma How many genetic changes are needed for neoplastic transformation?... if you have some of these changes, but not all, you will never become
More informationTransgene Presents Additional Positive Clinical Data from Phase 2b Part of TIME Trial with TG4010 at ESMO
Transgene Presents Additional Positive Clinical Data from Phase 2b Part of TIME Trial with TG4010 at ESMO Statistically significant difference in progression-free survival continues to be seen in non-squamous
More informationImmune Therapy for Pancreatic Cancer
Immune Therapy for Pancreatic Cancer December 16, 2014 If you experience technical difficulty during the presentation: Contact WebEx Technical Support directly at: US Toll Free: 1-866-229-3239 Toll Only:
More informationCURRICULUM VITAE. 9/61 to 6/62 Pre-Med Kansas State Teachers College Emporia, KS
Date: October 21, 2010 CURRICULUM VITAE PERSONAL DATA First Name David Last Name Deer Current Academic Rank Clinical Assistant Professor Department(s) Radiation Oncology Office Address 3901 Rainbow Blvd.,
More informationDr. SUNDAR RAMALINGAM BDS, MDS, MFDS(Glasg.), FFDRCS (Ire.)
Dr. SUNDAR RAMALINGAM BDS, MDS, MFDS(Glasg.), FFDRCS (Ire.) Oral and Maxillofacial Surgeon smunusamy@ksu.edu.sa / drsundar_mds@yahoo.com +966 53 20 92 386 Educational Qualifications Certificate Obtained
More informationCHRYSANTHI KOUTSIVITI
CHRYSANTHI KOUTSIVITI Ph: +1 773-517-7958 hryssanthi@hotmail.com Professional Summary Accomplished and energetic researcher and instructor with a solid history of achievement in teaching. Motivated leader
More informationHuman Health Sciences
Human Health Sciences WITH PLYMOUTH UNIVERSITY DISCOVER MORE If you would like to visit Plymouth and meet our staff, then why not come along to one of our open days. Human Health Sciences WITH PLYMOUTH
More informationOncos Therapeutics: ONCOS THERAPEUTICS Personalized Cancer Immunotherapy. March 2015. Antti Vuolanto, COO and co-founder
Oncos Therapeutics: Personalized Cancer Immunotherapy ONCOS THERAPEUTICS Personalized Cancer Immunotherapy March 2015 Antti Vuolanto, COO and co-founder 1 History of Oncos Therapeutics 2002 2007 2009 Research
More informationMoving forward, where are we with Clinical Trials?
Moving forward, where are we with Clinical Trials? Dennis A. Wigle Division of Thoracic Surgery Mayo Clinic AATS/STS General Thoracic Surgery Symposium Sunday, April 27 th 2014 2012 MFMER slide-1 Where
More informationFINAL REPORT For Japan-Korea Joint Research Project AREA
(Form4-2) FINAL REPORT For Japan-Korea Joint Research Project AREA 1. Mathematics & Physics 2. Chemistry & Material Science 3. Biology 4. Informatics & Mechatronics 5. Geo-Science & Space Science 6. Medical
More informationAppendices Master s degree programme Biomedical Engineering 2011-2012
Appendices Master s degree programme Biomedical Engineering 2011-2012 Appendix A Learning outcomes of the degree programme (art. 1.3) The graduate in Biomedical Engineering (BME): 1. has basic knowledge
More informationOvarian Cancer and Modern Immunotherapy: Regulatory Strategies for Drug Development
Ovarian Cancer and Modern Immunotherapy: Regulatory Strategies for Drug Development Sanjeeve Bala, MD, MPH Ovarian Cancer Endpoints Workshop FDA White Oak September 3, 2015 Overview Immune agents from
More informationTeaching Medicine and Teaching Science: Is there a difference? From MD to PhD (Clinical Researcher) Ines Vaz Luis September 2013
Teaching Medicine and Teaching Science: Is there a difference? From MD to PhD (Clinical Researcher) Ines Vaz Luis September 2013 Disclosures I have no disclosures But. I have a WARNING: This talk is largely
More informationPX Therapeutics : the partner for early stage biotherapeutics development Biotuesday, May 5 2009
PX Therapeutics : the partner for early stage biotherapeutics development Biotuesday, May 5 2009 Christelle Dagoneau, PhD Business Development Director Company Profile Protein expert incorporated in 2000
More information18.5 Percent Overall Response Rate Observed in Pembrolizumab-Treated Patients with this Aggressive Form of Breast Cancer
News Release Media Contacts: Annick Robinson Investor Contacts: Joseph Romanelli (514) 837-2550 (908) 740-1986 Stephanie Lyttle NATIONAL Public Relations (514) 843-2365 Justin Holko (908) 740-1879 Merck
More information1) Aug 2005 In Vitro Chromosomal Aberration Study Cytotoxicity (File: TS39) Conclusion No cytotoxicity can be detected at concentrations up to 100%.
Endotoxicity and Cytotoxicity Studies 1) Aug 2005 In Vitro Chromosomal Aberration Study Cytotoxicity (File: TS39) Chinese Hamster Ovary (CHO) cells were grown in monolayer with and without metabolic activation.
More informationCareer Opportunities in Physiology Committee
Career Opportunities in Physiology Committee Careers Symposium This annual EB Careers session is intended to address the specific objective in the 2000 APS Strategic Plan, to promote interest in and understanding
More informationDEPARTMENT OF IMMUNOLOGY Chair of Histology and Immunology Medical University of Gdańsk
DEPARTMENT OF IMMUNOLOGY Chair of Histology and Immunology Medical University of Gdańsk Research group Head: Jolanta Myśliwska, MD, PhD Professor of immunology Joanna Więckiewicz, M. Sc. Dominik Rachoń,
More informationBayer Invests Heavily in R&D and is committed to innovation Sustained Innovation Output from all Subgroups
Open Innovation@BayerHealthCare Dr. Daniel Forler External Innovation Therapeutics Global Drug Discovery, Bayer HealthCare ASTP-Proton Conference Page 1 Bayer Invests Heavily in R&D and is committed to
More informationNEW ADVANCES IN MYOCARDIAL INFARCTION THERAPY: THE REGENERATION APPROACH
NEW ADVANCES IN MYOCARDIAL INFARCTION THERAPY: THE REGENERATION APPROACH Giovanni Esposito, MD, PhD Dipartimento di Cardiologia, Cardiochirurgia ed Emergenze Cardiovascolari Laboratorio di Emodinamica
More informationColorectal cancer xenopatients: A preclinical platform for precision medicine
Colorectal cancer xenopatients: A preclinical platform for precision medicine Livio Trusolino, MD PhD Laboratory of Molecular Pharmacology IRCC, Institute for Cancer Research and Treatment University of
More information